Introduction
Many temperate-zone rodents display seasonal alterations in immune function; typically immune function is enhanced prior to the onset of demanding winter conditions (Nelson et al., 1995; Demas and Nelson, 1998) . Numerous field studies have reported seasonal alterations in immune function in a variety of species, whereas laboratory studies have focused on the role of photoperiod in modulating immune function (reviewed in Nelson and Demas, 1996) . In general, in the laboratory, exposure to short-day lengths leads to enhanced immune function compared to animals maintained in long days (Vaughan et al., 1987; Brainard et al., 1988; Champney and McMurray, 1991; Nelson and Blom, 1994; Blom et al., 1994; Nelson and Demas, 1996; Demas and Nelson, 1998) .
The role of melatonin in mediating the effects of photoperiod on reproduction has been well-established (Nelson et al., 1990; Bartness et al., 1993) . However, the role of melatonin in mediating photoperiodic changes in immune function has not been systematically investigated (but see Yellon et al., 1999) . Thus, it is reasonable to postulate that seasonal changes in the duration of melatonin secretion may mediate seasonal alterations in immune function (Brainard et al., 1988; Champney and McMurray, 1991; Champney et al., 1998) . Likewise, it is reasonable to speculate that individuals within a species that vary in reproductive response to photoperiod may also vary in ''immuno-responsiveness'' to melatonin.
Melatonin may act either directly or indirectly to influence immune function. For example, melatonin receptors have been identified directly on circulating lymphocytes, splenocytes, and thymocytes (Lopez-Gonzales et al., 1992; Calvo et al., 1995; Rafii-El-Idrissi et al., 1995) , and in vivo melatonin treatment enhances immune function (Guerrero and Reiter, 1992; Maestroni, 1993; Demas and Nelson, 1998) . Melatonin could also act indirectly on various aspects of immune function. In addition to melatonin, several hormones vary with photoperiod, such as gonadal steroid hormones, prolactin, and glucocorticosteroids, hormones that can affect immune function (Gaston and Menaker, 1967; Johnston and Zucker, 1979; Bartness et al., 1993) .
The present study used prairie voles (Microtus ochrogaster), a species that exhibits a phenotypic polymorphism in reproductive responsiveness to photoperiod, to study whether or not the mechanisms governing seasonal changes in reproductive function also influence seasonal changes in immune function. Apparently, all seasonal adaptations are not ''linked'' to seasonal changes in reproduction (e.g. Smale et al., 1988; Nelson et al., 1989) . Thus, the use of male prairie voles allows the determination of the dependence of seasonal alterations in immune function on physiological changes associated with reproductive quiescence. Likewise, the use of rodents that vary in reproductive responsiveness to photoperiod (and presumably melatonin concentrations or sensitivity to melatonin), allows the investigation of whether or not the initiation of other adaptations (i.e. immune function) also exhibit variable sensitivity to melatonin. Specifically, the present study had two general goals. The first goal was to determine whether or not extended exposure to long (i.e. short days) or short (i.e. long days) durations of endogenous melatonin influence basal levels of in vitro splenocyte proliferation, or splenocyte proliferation in response to the mitogen, Concanavalin A (Con A). Second, we sought to determine whether or not melatonin exerts direct effects on basal splenocyte proliferation or proliferation in response to Con A, as well as the potential effects of prior photoperiod exposure and reproductive condition on the response to melatonin in vitro.
Methods

Animals
Forty adult (\60 days of age) male prairie voles (Microtus ochrogaster) were obtained from our laboratory breeding colony. All animals were individually housed in polycarbonate cages (28× 17×12 cm) in colony rooms with a 16:8 h light -dark (LD) cycle [lights on at 07:00 h Eastern Standard Time] until the onset of the experiment. Colony rooms were maintained with an ambient temperature of 2192°C, and relative humidity was held constant at 5095%. Food (LabDiet 5001; PMI Nutrition, Brentwood, MO) and tap water were provided ad libitum throughout the course of the study.
Treatment
At the onset of the experiment, animals were moved to either long (LD 16:8, lights on 07:00 h EST; n =5) or short (LD 8:16, lights on 07:00 h; n =35) photoperiods for 10 wk. After 10 wk of exposure to the photoperiodic condition, animals were lightly anesthetized with methoxyflurane vapors (Metofane: Pitman-Moore, Mundelein, IL), weighed, and a blood sample was obtained from the retro-orbital sinus. Voles were then killed (4 hr after lights off for all conditions) by cervical dislocation and their spleens were removed under aseptic conditions and were immediately suspended in culture medium (RPMI). Paired testes, paired epididymides, seminal vesicles, epididymal fat, and brown fat masses were recorded at autopsy. Paired testes mass was used to separate short-day animals into responders (R) and non-responders (NR). Animals with testes masses \500 mg were considered NR (n=7) while voles with testes masses B300 mg were considered R (n=7) (Nelson et al., 1989) . Animals in short days with an intermediate degree of testicular regression were not used.
Splenocyte proliferation
Cell-mediated immune function was assessed by measuring splenocyte proliferation in response to the T-cell mitogen, Con A, using a colormetric assay based on the tetrazolium salt 3-(4,5-demethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS). Splenocytes were separated from tissue by compressing the whole spleen between sterile frosted glass slides; separated cells were suspended in 3 mL of culture medium (RPMI-1640/Hepes supplemented with 1% penicillin (5000 U/mL)/streptomycin (5000 mL/mL), 1% L-glutamine (2 mM/mL), 0.1% 2-mercaptoethanol (5×10 − 2 M/ mL), and 10% heat-inactivated fetal bovine serum). Splenocyte counts and viability were determined with a hemacytometer and trypan blue exclusion. Viable cells (which exceed 95%) were adjusted to 2×10 6 cells/mL by dilution with culture medium, and 50 mL aliquots of each cell suspension (i.e. 100,000 cells) were added to the wells of sterile flat-bottom 96-well culture plates. Con A (Sigma Chemical Co., St Louis, MO) was diluted with culture medium to concentrations of 40, 20, 10 mg/mL; 50 mL of each mitogen concentration was added to the wells of the plate that would contain the spleen cell suspensions to yield a final volume of 100 mL/well (each in duplicate) for those wells to which melatonin was not added. Melatonin (Sigma Chemical Co., St Louis, MO) was dissolved in ethanol and diluted in RPMI-1640 medium to a standard stock solution. Then, 100 mL of 500 pg/mL melatonin was added to half of the wells that would contain the spleen cell suspensions, to yield a final volume of 200 mL/well (each in duplicate). Both Con A and melatonin were added to the plates prior to the addition of cells. Plates were incubated at 37°C with 5% CO 2 for 48 hr prior to addition of 20 mL of MTS/PMS solution (Promega, Madison, WI; 0.92 mg/mL of phenazine methosulphate (PMS) in sterile Dulbecco's phosphate buffered saline) per well. Plates were then incubated at 37°C with 5% CO 2 for an additional 4 hr. The optical density (OD) of each well was determined with a microplate reader (Bio-Rad, Hercules, CA, Benchmark) equipped with a 490-nm wavelength filter. Mean OD values for each set of duplicates were used in subsequent statistical analyses. Dose response curves were constructed using group means of the mean OD values at each mitogen concentration and unstimulated cultures.
Statistical analyses
All autopsy data were analyzed using a series of one-way analyses of variance (ANOVA). Proliferative responses were analyzed using a mixed overall ANOVA with two within-subjects variables (i.e. mitogen concentration and melatonin treatment) and one between-subjects factor (i.e. photoperiod). Post-hoc comparisons between pairwise means were conducted using Tukey HSD tests where appropriate. All mean differences among treatment groups were considered significant if PB0.05.
Results
Reproductive organ masses and body mass are presented in Fig. 1 . Paired testes, epididymides, and seminal vesicle weights were significantly reduced in short-day Rs compared to both long-day and short-day NR animals (PB0.05). Body mass was unaffected by either photoperiod or reproductive condition (P \0.05).
Splenoctye proliferation was significantly elevated in cultures to which melatonin was added (PB0.01). Proliferative responses varied as a function of mitogen concentration, with optimal proliferative responses (i.e. the greatest amount of proliferative response) observed at 20 mg/mL of Con A (Fig. 2) . Melatonin enhanced splenocyte Fig. 1 . Mean reproductive organ and body masses ( 9 S.E.M.) of male prairie voles housed for 10 wk in long-day lengths (LD 16:8) or voles maintained on short days (LD 8:16) that either responded (R) or did not respond (NR) to inhibitory day lengths with reproductive regression. * Significantly less than both long-day voles and short-day animals that did not undergo reproductive regression (P B0.05). proliferation under basal conditions without stimulation by Con A (P B0.01). A similar enhancement of proliferation was observed at all Con A doses (PB0.001 in each case). Overall, photoperiod or reproductive condition did not affect splenocyte proliferation (P\ 0.05 in each case; Fig. 2 ).
Discussion
Splenocyte proliferation in response to the T-cell mitogen Con A was enhanced by the addition of melatonin in vitro compared to cultures that did not receive melatonin. In contrast, photoperiod and reproductive condition did not significantly influence splenocyte proliferation under basal conditions, or in response to mitogen treatment. These findings suggest that melatonin enhances immune function in male voles, and this responsiveness to exogenous melatonin is not modulated by photoperiod or reproductive condition. The observation that reproductive responsiveness is not associated with alterations in immune function suggests that melatonin concentrations may be similar among short-day reproductive Rs and NRs, and mechanisms downstream from melatonin production (e.g. reduced receptor affinity or numbers) may account for differences in reproductive status. Alternatively, because photoperiod (and presumably alterations in endogenous melatonin concentrations) did not alter immune function, endogenous changes in the duration of melatonin secretion may not lead to pronounced changes in immune function in prairie voles, whereas exogenous (i.e. higher concentrations) melatonin may be necessary to enhance immune function in this species.
The immuno-enhancing effects of melatonin in the present study are consistent with previous findings demonstrating enhanced immunity after melatonin treatment in several species. For example, in vivo melatonin administration leads to changes in splenic mass (Vaughan et al., 1987; Brainard et al., 1988; Champney and McMurray, 1991) . Exogenous melatonin also enhances cell-mediated immune function in deer mice (Demas and Nelson, 1998) . In addition, in vitro and in vivo antibody responses of both normal and immuno-compromised house mice are elevated after melatonin treatment (Caroleo et al., 1992; Maestroni, 1993) .
Thus, melatonin may act directly or indirectly to affect immune function. Melatonin can act directly on high affinity membrane or nuclear receptors located on immune cells to increase immune function (Pang and Pang, 1992; Calvo et al., 1995; Garcia-Maurino et al., 1997; Reppert, 1997; RafiiEl-Idrissi et al., 1998) . Consistent with this idea, high-affinity melatonin receptors have been localized on circulating lymphocytes (Pang and Pang, 1992; Calvo et al., 1995) , as well as on thymocytes and splenocytes (Lopez-Gonzales et al., 1992; Martin-Cacao et al., 1993; Rafii-El-Idrissi et al., 1995) . Likewise, a ligand (RZR/ROR) of the nuclear melatonin receptor enhances IL-2 and IL-6 production in cultured human lymphocytes (Garcia-Maurino et al., 1997) , thereby providing evidence for a direct effect of melatonin on nuclear receptors.
Photoperiod did not affect splenocyte proliferation to Con A in the present study. These results differ from those reported for deer mice and hamsters in which short-day lengths enhance immune function (Brainard et al., 1988; Demas and Nelson, 1998; Yellon et al., 1999) . One previous study in female prairie voles found that melatonin enhances splenocyte proliferation in vitro, and photoperiod did not affect this immune parameter (Drazen et al., 1999) . However, female voles are not strongly reproductively responsive to photoperiod (Nelson, 1985) . Instead, female voles have undetectable concentrations of estradiol in both long and short days until induced into estrus by chemosensory cues found in male urine; in the absence of males, females remain reproductively quiescent (Richmond and Conway, 1969; Nelson, 1985) . Because reproductive physiology and immune function are not affected by photoperiod in female voles, we hypothesized that seasonal changes in immune function may be ''linked'' to reproductive responsiveness to photoperiod in male prairie voles Thus, it seemed reasonable that photoperiod-mediated changes in immune function in male voles may be associated with changes in reproductive function. The results of the present study, in combination with one previous study in female prairie voles (Drazen et al., 1999) , suggest that both male and female voles may not exhibit robust immune changes in response to photoperiod. Because factors in addition to photoperiod are used by animals in nature to phase seasonal adaptations, future studies are necessary to determine the extent to which proximate factors other than (or in addition to) photoperiod may influence immune function in this species.
In the present study, all animals were killed during the light portion of the LD cycle. However, melatonin is secreted only during the dark portion of the LD cycle (reviewed in Cassone, 1990; Reiter, 1993) . Because prairie voles are nocturnal, and energy is invaluable when food is limited during winter, melatonin may only act to enhance immune function during the night in order to conserve energy during the day while animals are buffered from inclement conditions in their burrows and microclimates. This hypothesis may account for a failure to find alterations in basal, mitogen-stimulated, or melatonin-enhanced immune function among groups. Although reports in Siberian hamsters and deer mice (e.g. Demas and Nelson, 1998) suggest that time-of-sacrifice does not ''mask'' seasonal changes in immune function, species differences due to varied life history strategies require that future studies are conducted in which immune function is evaluated in prairie voles killed during both the light and dark portions of the LD cycle.
Taken together, the results of this study demonstrate that in vitro melatonin treatment enhances cell-mediated immunity in male prairie voles. In addition, these findings support the hypothesis that melatonin exerts a direct effect on splenocyte proliferation, possibly via high-affinity melatonin receptors localized on splenocytes. Photoperiod and reproductive condition did not affect splenocyte proliferation in the present study. This finding suggests that immune function in prairie voles may not be sensitive to changes in day length. Future studies are required to determine the extent to which exposure to additional proximate factors may uncover seasonal changes in immune function in prairie voles.
